Piramal Pharma consolidated net profit rises 350.00% in the September 2024 quarter
Sales rise 17.28% to Rs 2241.75 crore
Net profit of Piramal Pharma rose 350.00% to Rs 22.59 crore in the quarter ended September 2024 as against Rs 5.02 crore during the previous quarter ended September 2023. Sales rose 17.28% to Rs 2241.75 crore in the quarter ended September 2024 as against Rs 1911.38 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales2241.751911.38 17 OPM %15.2413.90 -PBDT312.34224.07 39 PBT120.1239.56 204 NP22.595.02 350Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 24 2024 | 7:30 AM IST